Konstantinos C Koskinas

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 5

Top Topics

Thoracic Surgery

Affordable Care Act

Cardiovascular Disease

Top Venues

European journal of preventive cardiology

Clinical cardiology

This page only lists publications with an associated author ORCID identifier.

Publications

Konstantinos C Koskinas, Matthias Wilhelm, Martin Halle, Alessandro Biffi, Elena Cavarretta, Constantinos H Davos, Ines Frederix, M Hemmat Gaber, Dominique Hansen, Jennifer L Jones, Aneil Malhotra, Michael Papadakis
The future of education in Preventive Cardiology. A Statement of the European Association of Preventive Cardiology (EAPC) of the ESC. European journal of preventive cardiology (2024)
Konstantinos C Koskinas, Emeline Van Craenenbroeck, Charalambos Antoniades, Matthias Blüher, Thomas M Gorter, Henner Hanssen, Nikolaus Marx, Theresa A McDonagh, Geltrude Mingrone, Annika Rosengren, Eva Irene Bossano Prescott
Obesity and cardiovascular disease: an ESC clinical consensus statement. European journal of preventive cardiology (2024)
Konstantinos C Koskinas, Matthias Wilhelm, Martin Halle, Alessandro Biffi, Elena Cavarretta, Constantinos H Davos, Ines Frederix, M Hemmat Gaber, Dominique Hansen, Jennifer L Jones, Aneil Malhotra, Michael Papadakis
The future of education in Preventive Cardiology. A Statement of the European Association of Preventive Cardiology (EAPC) of the ESC. European journal of preventive cardiology (2024)
Konstantinos C Koskinas, Paul Dendale, Martin Halle, Stefano Caselli, Veronique Cornelissen, Maryam Kavousi, Donata Kurpas, Elena Osto, Tobias Raupach, Anne Grete Semb, Roberto F E Pedretti
Introducing the new Task Force on Cardiovascular Risk Factors of the European Association of Preventive Cardiology. European journal of preventive cardiology 29 (13) (2022)
Konstantinos C Koskinas, Stephan Windecker, Aliki Buhayer, Baris Gencer, Giovanni Pedrazzini, Christian Mueller, Stephan Cook, Olivier Muller, Christian M Matter, Lorenz Räber, Dik Heg, François Mach, null null
Design of the randomized, placebo-controlled evolocumab for early reduction of LDL-cholesterol levels in patients with acute coronary syndromes (EVOPACS) trial. Clinical cardiology 41 (12) (2018)